Quick Takeaways
- 1Globe Capital LLC filed SCHEDULE 13G/A for Crescent Biopharma, Inc. Ordinary Shares, par value $0.001 per share (CBIO).
- Disclosed ownership: 10%.
- Date of event: 07 Oct 2025.
1Globe Capital LLC - 07 Oct 2025 SCHEDULE 13G/A Report for Crescent Biopharma, Inc. Ordinary Shares, par value $0.001 per share (CBIO)
- Filing Manager
- 1Globe Capital LLC
- Reporting Manager
- 1Globe Capital LLC
- Symbol
- CBIO
- Shares outstanding
- 13,839,146 shares
- Disclosed Ownership
- 1,425,432 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Oct 2025, 15:41:05 UTC
- Date of event
- 07 Oct 2025
- Previous filing
- 20 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"1Globe Capital LLC disclosed 10% ownership in Crescent Biopharma, Inc. Ordinary Shares, par value $0.001 per share (CBIO) on 07 Oct 2025."
What Changed
- Previous schedule filing date: 20 Aug 2025.
- Current filing was accepted on 14 Oct 2025, 15:41.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| 1Globe Capital LLC | 10% | 1,425,432 | 0 | 1,425,432 | /s/ Jiaqiang Li | Chairman | |
| Jiaqiang Li | 10% | 1,425,432 | 0 | 1,425,432 | /s/ Jiaqiang Li | Reporting person |